Literature DB >> 19362498

A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections.

O Ehsan1, C P Gibbons.   

Abstract

BACKGROUND: Infected prosthetic grafts and mycotic aneurysms carry a high mortality and morbidity rate, with a substantial risk of persistent graft infection, but there is evidence that this can be minimised by using femoro-popliteal vein for arterial reconstruction after debridement and graft excision. We present our 10-year experience of this technique.
METHODS: Forty-six patients underwent 48 arterial reconstructions with femoro-popliteal vein (24 aortic). Six had mycotic aneurysms (three aortic) and 40 had graft infections (16 aortic).
RESULTS: There were two early postoperative deaths (4.3%) and two patients with pre-existing ischaemia underwent major amputation despite a patent graft. Median follow-up was 4.1 ears (range: 2 months to 10 years). Patient survival was 70% and limb salvage 96% at 5 years. Primary graft patency was 75% and 62% and secondary patency 93% and 91% at 2 and 5 years, respectively. Two patients required further surgery for recurrent infection. Anastomotic or graft stenosis occurred in 11 patients (24%). There were three major wound infections. Donor-limb swelling was transient.
CONCLUSION: For arterial and prosthetic graft infections, femoro-popliteal vein is an excellent conduit for vascular reconstruction after drainage and debridement of infected tissue and graft material under antibiotic cover, providing good long-term survival and limb salvage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362498     DOI: 10.1016/j.ejvs.2009.03.009

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  10 in total

1.  Salmonella-related mycotic pseudoaneurysm of the superficial femoral artery.

Authors:  Marcus Vinícius Martins Cury; Maysa Heineck de Campos; Diogo Pires Dos Santos
Journal:  Int J Surg Case Rep       Date:  2011-10-25

2.  Reconstruction with the use of autologous femoropopliteal veins for an infected aortobifemoral bypass graft.

Authors:  Jakub Kaczynski; Steve Atherton; Christopher G Davies; Colin J Ferguson
Journal:  BMJ Case Rep       Date:  2013-02-20

3.  Surgical outcome for mycotic aortic and iliac anuerysm.

Authors:  Sheng-Yueh Yu; Hung-Chang Hsieh; Po-Jen Ko; Yao-Kuang Huang; Jaw-Ji Chu; Chun-Hui Lee
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

4.  Hybrid treatment for lower limb revascularization in a patient with vascular graft infection: a case report.

Authors:  Eduardo Lichtenfels; Nilon Erling; Newton Roesch Aerts; Andre Silvestri Reitz da Costa
Journal:  J Vasc Bras       Date:  2022-05-10

5.  Treatment strategies for aortic and peripheral prosthetic graft infection.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Masatoshi Jibiki; Norihide Sugano; Yoshinori Inoue
Journal:  Surg Today       Date:  2013-04-05       Impact factor: 2.549

6.  Contralateral internal iliac artery transposition for retroperitoneal sarcoma involving common iliac artery.

Authors:  Cheng-Peng Li; Bo-Nan Liu; Jian-Hui Wu; Chun-Yi Hao
Journal:  Updates Surg       Date:  2020-06-29

7.  Minimally invasive treatment of vascular complications after neoaortoiliac system reconstruction using autologous vein grafts.

Authors:  Jeroen J W M Brouwers; Tarik R Baetens; Jan van Schaik
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-12-04

8.  Remote endarterectomy to remove infected Viabahn stent-graft.

Authors:  Christopher L Tarola; Morgan Young-Speirs; John W D Speirs; Carman M Iannicello
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-20

9.  In Situ Aortic Reconstruction with Femoral Vein after Post-EVAR Infection.

Authors:  Hong Kyung Shin; Jae Young Park; Taeseung Lee
Journal:  Vasc Specialist Int       Date:  2014-06-30

10.  Operative technique and morbidity of superficial femoral vein harvest.

Authors:  A Neufang; S Savvidis
Journal:  Gefasschirurgie       Date:  2016-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.